Omri Weisman1, Yael Schonherz2, Tal Harel2, Martin Efron2, Maya Elazar2, Doron Gothelf3. 1. The Child and Adolescent Psychiatry Divison, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. 2. The Child and Adolescent Psychiatry Divison, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel. 3. The Child and Adolescent Psychiatry Divison, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract
BACKGROUND: Adherence to medication is a key factor for successful treatment of children with ADHD. However, most children do not adhere to their pharmacotherapy regimen, and have no contact with their physician during the first month of pharmacotherapy. A mobile health (mHealth) approach may bridge the gap between physicians and patients, allowing for more frequent communications as well as better monitoring of adherence to the prescribed treatment. METHOD: The study sample included 39 children with ADHD (27 boys), aged 9.56±2.41 years. Participants were randomly assigned to one of the following two groups: (1) a study group in which participants and their parents were prompted to use a mobile application (i.e., mobile app or app); or to (2) a control group in which participants were treated as usual, without the app. Pill counts, which is a common strategy for confirming medication adherence, was recorded at week 4 and week 8. Clinical assessment conducted at baseline, week 4, and week 8. RESULTS: Participants who were prescribed with the app demonstrated higher overall pill counts over 8-weeks period, F=4.33, p<.05. In addition, a significant improvement in total CRS score was found among the study group compared to controls in week 4 and week 8, F=4.74, p<.05. CONCLUSIONS: The current study provides initial support for the feasibility of a new mobile app in promoting adherence to stimulants among youth with ADHD.
RCT Entities:
BACKGROUND: Adherence to medication is a key factor for successful treatment of children with ADHD. However, most children do not adhere to their pharmacotherapy regimen, and have no contact with their physician during the first month of pharmacotherapy. A mobile health (mHealth) approach may bridge the gap between physicians and patients, allowing for more frequent communications as well as better monitoring of adherence to the prescribed treatment. METHOD: The study sample included 39 children with ADHD (27 boys), aged 9.56±2.41 years. Participants were randomly assigned to one of the following two groups: (1) a study group in which participants and their parents were prompted to use a mobile application (i.e., mobile app or app); or to (2) a control group in which participants were treated as usual, without the app. Pill counts, which is a common strategy for confirming medication adherence, was recorded at week 4 and week 8. Clinical assessment conducted at baseline, week 4, and week 8. RESULTS:Participants who were prescribed with the app demonstrated higher overall pill counts over 8-weeks period, F=4.33, p<.05. In addition, a significant improvement in total CRS score was found among the study group compared to controls in week 4 and week 8, F=4.74, p<.05. CONCLUSIONS: The current study provides initial support for the feasibility of a new mobile app in promoting adherence to stimulants among youth with ADHD.
Authors: Rachel M Morse; Hanlie Myburgh; David Reubi; Ava E Archey; Leletu Busakwe; Anthony J Garcia-Prats; Anneke C Hesseling; Stephanie Jacobs; Sharon Mbaba; Kyla Meyerson; James A Seddon; Marieke M van der Zalm; Dillon T Wademan; Graeme Hoddinott Journal: JMIR Mhealth Uhealth Date: 2020-11-11 Impact factor: 4.773
Authors: Elisa Fucà; Floriana Costanzo; Dimitri Bonutto; Annarita Moretti; Andrea Fini; Alberto Ferraiuolo; Stefano Vicari; Alberto Eugenio Tozzi Journal: Int J Environ Res Public Health Date: 2021-03-09 Impact factor: 3.390